HUMAN NORMAL IMMUNOGLOBULIN 50 mg/ml - rezultati pretrage

panzyga 100mg/ml solution for infusion (2.5g/25ml)

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - human normal, immunoglobulin - solution for infusion - human normal immunoglobulin 100 mg/ml - immune sera and immunoglobulins

Malta - engleski - Medicines Authority

panzyga 100mg/ml solution for infusion (5g/50ml)

Malta - engleski - Medicines Authority

panzyga 100mg/ml solution for infusion (6g/60ml)

Malta - engleski - Medicines Authority

panzyga 100mg/ml solution for infusion (10g/100ml)

Malta - engleski - Medicines Authority

panzyga 100mg/ml solution for infusion (30g/30ml)

Singapur - engleski - HSA (Health Sciences Authority)

flebogamma dif solution for infusion 5%

grifols asia pacific pte. ltd. - human normal immunoglobulin - infusion, solution - 50 mg/ml - human normal immunoglobulin 50 mg/ml

Australija - engleski - Department of Health (Therapeutic Goods Administration)

octagam normal immunoglobulin (human) 10g/200ml injection bottle

octapharma australia pty ltd - human immunoglobulin g, quantity: 50 mg/ml - injection - excipient ingredients: octoxinol 10; water for injections; tributyl phosphate; maltose; human immunoglobulin a - replacement therapy: primary immunodeficiency syndromes: congenital agammaglobulinaemia and hypogammaglobulinaemia; common variable immunodeficiency; severe combined immunodeficiencies; wiskott aldrich syndrome; myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections. children with congenital acquired immune deficiency syndrome (aids) who have repeated bacterial infections; immunomodulatory effect: idiopathic thrombocytopenic purpura, in adults or children with a high risk of bleeding or prior to surgery to correct platelet count. guillain barre syndrome. kawasaki disease. allogeneic bone marrow transplantation.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

octagam normal immunoglobulin (human) 5g/100ml injection bottle

octapharma australia pty ltd - human immunoglobulin g, quantity: 50 mg/ml - injection - excipient ingredients: maltose; human immunoglobulin a; octoxinol 10; water for injections; tributyl phosphate - replacement therapy: primary immunodeficiency syndromes: congenital agammaglobulinaemia and hypogammaglobulinaemia; common variable immunodeficiency; severe combined immunodeficiencies; wiskott aldrich syndrome; myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections. children with congenital acquired immune deficiency syndrome (aids) who have repeated bacterial infections; immunomodulatory effect: idiopathic thrombocytopenic purpura, in adults or children with a high risk of bleeding or prior to surgery to correct platelet count. guillain barre syndrome. kawasaki disease. allogeneic bone marrow transplantation.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

octagam normal immunoglobulin (human) 2.5g/50ml injection bottle

octapharma australia pty ltd - human immunoglobulin g, quantity: 50 mg/ml - injection - excipient ingredients: water for injections; octoxinol 10; human immunoglobulin a; tributyl phosphate; maltose - replacement therapy: primary immunodeficiency syndromes: congenital agammaglobulinaemia and hypogammaglobulinaemia; common variable immunodeficiency; severe combined immunodeficiencies; wiskott aldrich syndrome; myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections. children with congenital acquired immune deficiency syndrome (aids) who have repeated bacterial infections; immunomodulatory effect: idiopathic thrombocytopenic purpura, in adults or children with a high risk of bleeding or prior to surgery to correct platelet count. guillain barre syndrome. kawasaki disease. allogeneic bone marrow transplantation.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

octagam normal immunoglobulin (human) 1g/20ml injection vial

octapharma australia pty ltd - human immunoglobulin g, quantity: 50 mg/ml - injection - excipient ingredients: human immunoglobulin a; octoxinol 10; tributyl phosphate; maltose; water for injections - replacement therapy: primary immunodeficiency syndromes: congenital agammaglobulinaemia and hypogammaglobulinaemia; common variable immunodeficiency; severe combined immunodeficiencies; wiskott aldrich syndrome; myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections. children with congenital acquired immune deficiency syndrome (aids) who have repeated bacterial infections; immunomodulatory effect: idiopathic thrombocytopenic purpura, in adults or children with a high risk of bleeding or prior to surgery to correct platelet count. guillain barre syndrome. kawasaki disease. allogeneic bone marrow transplantation.